We found that treatment with sorafenib (20 μM) for 6 and 12 h induces the cleavage of the pro-apoptotic Bid protein to generate the truncated form tBid, resulting in a reduction in Bid (p22) expression and a parallel increase in tBid (p15) expression (Fig. 4A).
![[This page as RDF]](http://data.gesis.org/somesci/static/rdf-icon.gif){kind=icon}